跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,872 条关于
“K-Ras G12V”
全部
9,872
临床试验
4,675
药物
853
机构
283
资讯
4,061
9个月前
Akari Therapeutics Reports Promising Preclinical Data for AKTX-101 in K-Ras Mutant Pancreatic Cancer
2年前
Quanta Therapeutics' QTX3034 Receives FDA IND Clearance for KRASG12D-Mutated Solid Tumors
去年
Revolution Medicines Advances First-in-Class KRAS(G12D) Molecular Glue Inhibitor RMC-9805 with Novel Cyclophilin A Mechanism
2年前
Revolution Medicines' RMC-6236: A Novel Pan-RAS(ON) Inhibitor Shows Promise in 'Undruggable' Tumors
11个月前
Revolution Medicines Appoints Alan Sandler as Chief Development Officer to Advance RAS-Targeted Cancer Pipeline
6个月前
Quanta Therapeutics' Direct KRAS Inhibitors Show Promise Against Resistance to Pan-RAS Tri-Complex Therapies
上个月
KRAS G12C: From 'Undruggable' to Druggable with Sotorasib and Adagrasib
去年
Quanta Therapeutics' QTX3544 Receives FDA IND Clearance for KRASG12V-Driven Solid Tumors
2年前
Phase 1 Clinical Trial Underway for QTX3046 in KRASG12D-Mutated Advanced Solid Tumors
上个月
BeOne Medicines and Revolution Medicines Forge Multi-Part Collaboration to Advance RAS(ON) Inhibitors for RAS-Addicted Cancers
第 1 页,共 407 页
上一页
下一页